N/A N=50 Randomized Single-blind Treatment

Intervention for Battered Sheltered Women With Substance Use Randomized Trial

Intimate Partner Violence

Bottom Line

View on ClinicalTrials.gov: NCT02629133 ↗

Enrolled (actual)

Serious AEs

62.0%

Results posted

Apr 2020

Primary outcome: Primary: Alcohol and Substance Use: Timeline Follow-back (TLFB)-Modified Computer Version — 0.54; 0.66; 0.12; 0.29 % days of drug use or heavy drinking — p=0.560

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: SHE Program (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: Female
Sponsor: Women and Infants Hospital of Rhode Island
Primary completion: Dec 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Alcohol and Substance Use: Timeline Follow-back (TLFB)-Modified Computer Version	0.54; 0.66; 0.12; 0.29; 0.21; 0.16	0.560
SECONDARY The Treatment Services Review (TSR)	0.00; 0.01; 0.00; 0.00; 0.00; 0.00	0.026 sig
SECONDARY The Composite Abuse Scale (CAS)	52.8; 74.4; 9.4; 17.7; 14.1; 4.9	0.325
SECONDARY The Cyber Stalking Scale	9.53; 7.39; 4.95; 3.30; 3.89; 2.00	0.192
SECONDARY Safety Behavior Checklist (SBC)	7.3; 7.3; 4.5; 5.7; 2.8; 4.9	0.119

Summary

This study developed and assessed an innovative, high-reach, easily implementable, low-cost computer-delivered intervention (Safe and Healthy Experiences; The SHE Program) that addresses known barriers in early identification and intervention with sheltered battered women with IPV (intimate partner violence) and substance use.

Eligibility Criteria

Inclusion Criteria

Women who are 18 or older, residents of a battered women's shelter, who are at risk substance users within the last 3 months as determined by the screener, the NIDA-Modified ASSIST, and endorse IPV within the last 3 months as determined by the screener, the WAST (Woman Abuse Screening Tool)

Exclusion Criteria

Inability to provide informed consent (e.g., due to florid psychosis or other clear cognitive impairment)
Inability to understand English

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02629133). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.